<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="brjclinpharm"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3703233/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>A semi-mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC3703233_files/jig.min.css"><script type="text/javascript" src="./PMC3703233_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="British Journal of Clinical Pharmacology"><meta name="citation_title" content="A semi-mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin"><meta name="citation_authors" content="Xavier Delavenne, Edouard Ollier, Thierry Basset, Laurent Bertoletti, Sandrine Accassat, Arnauld Garcin, Silvy Laporte, Paul Zufferey, Patrick Mismetti"><meta name="citation_date" content="July 2013"><meta name="citation_issue" content="1"><meta name="citation_volume" content="76"><meta name="citation_firstpage" content="107"><meta name="citation_doi" content="10.1111/bcp.12055"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3703233/?report=abstract"><meta name="citation_pmid" content="23210726"><meta name="DC.Title" content="A semi-mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Wiley-Blackwell"><meta name="DC.Contributor" content="Xavier Delavenne"><meta name="DC.Contributor" content="Edouard Ollier"><meta name="DC.Contributor" content="Thierry Basset"><meta name="DC.Contributor" content="Laurent Bertoletti"><meta name="DC.Contributor" content="Sandrine Accassat"><meta name="DC.Contributor" content="Arnauld Garcin"><meta name="DC.Contributor" content="Silvy Laporte"><meta name="DC.Contributor" content="Paul Zufferey"><meta name="DC.Contributor" content="Patrick Mismetti"><meta name="DC.Date" content="2013 Jul"><meta name="DC.Identifier" content="10.1111/bcp.12055"><meta name="DC.Language" content="en"><meta property="og:title" content="A semi-mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin"><meta property="og:type" content="article"><meta property="og:description" content="The aim of this study was to develop a PK/PD model to assess drug–drug interactions between dabigatran and P-gp modulators, using the example of clarithromycin, a strong inhibitor of P-gp.Ten healthy male volunteers were randomized to receive ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC3703233_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC3703233_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC3703233_files/common.min.js">//</script><script type="text/javascript" src="./PMC3703233_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC3703233_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC3703233_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC3703233_files/MathJax.js"></script><script type="text/javascript" src="./PMC3703233_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-brjclinpharm.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/pdf/bcp0076-0107.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="F4FC29EF76C290E10000000000413569"><link type="text/css" rel="stylesheet" href="./PMC3703233_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC3703233_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC3703233%2F&ncbi_pdid=article&ncbi_phid=F4FC29EF76C290E10000000000413569'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-jig-5"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC3703233_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a><ul id="resources-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/" tabindex="-1" role="menuitem">All Resources</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#chemicals-bioassays" tabindex="-1" role="menuitem" class="expandRight">Chemicals &amp; Bioassays</a><ul class="actual-resources-submenu chemicals-bioassays ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcassay" title=" Contributed bioactivity data for PubChem Substances " tabindex="-1" role="menuitem">PubChem BioAssay</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pccompound" title=" Unique, standardized chemical structures " tabindex="-1" role="menuitem">PubChem Compound</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcsubstance" title=" Provides information on the biological activities of small molecules. " tabindex="-1" role="menuitem">PubChem Substance</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/" tabindex="-1" role="menuitem">All Chemicals &amp; Bioassays Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#dna-rna" tabindex="-1" role="menuitem" class="expandRight">DNA &amp; RNA</a><ul class="actual-resources-submenu dna-rna ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/" title=" DNA and RNA sequences submitted to NCBI " tabindex="-1" role="menuitem">GenBank</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/" tabindex="-1" role="menuitem">All DNA &amp; RNA Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#data-software" tabindex="-1" role="menuitem" class="expandRight">Data &amp; Software</a><ul class="actual-resources-submenu data-software ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/" tabindex="-1" role="menuitem">All Data &amp; Software Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#domains-structures" tabindex="-1" role="menuitem" class="expandRight">Domains &amp; Structures</a><ul class="actual-resources-submenu domains-structures ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/structure/" title=" Database of 3D macromolecular structures derived from PDB " tabindex="-1" role="menuitem">Structure (Molecular Modeling Database)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/" tabindex="-1" role="menuitem">All Domains &amp; Structures Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#genes-expression" tabindex="-1" role="menuitem" class="expandRight">Genes &amp; Expression</a><ul class="actual-resources-submenu genes-expression ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gene" title=" Database of gene loci and associated transcripts and proteins " tabindex="-1" role="menuitem">Gene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geo/" title=" Gene Expression Omnibus (GEO) Database " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Database </a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gds" title=" Curated collections of gene expression data sets " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Datasets</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geoprofiles/" title=" Database of gene expression Profiles for individual sequences " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Profiles</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/" tabindex="-1" role="menuitem">All Genes &amp; Expression Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#genetics-medicine" tabindex="-1" role="menuitem" class="expandRight">Genetics &amp; Medicine</a><ul class="actual-resources-submenu genetics-medicine ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gtr/" title=" Detailed information about genetic tests and labs " tabindex="-1" role="menuitem">Genetic Testing Registry</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/" tabindex="-1" role="menuitem">All Genetics &amp; Medicine Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#genomes-maps" tabindex="-1" role="menuitem" class="expandRight">Genomes &amp; Maps</a><ul class="actual-resources-submenu genomes-maps ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sites/genome" title=" Curated genomic DNA sequences " tabindex="-1" role="menuitem">Genome</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/bioproject/" title=" Central status pages for genome sequencing projects " tabindex="-1" role="menuitem">Genome Project</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/" tabindex="-1" role="menuitem">All Genomes &amp; Maps Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#homology" tabindex="-1" role="menuitem" class="expandRight">Homology</a><ul class="actual-resources-submenu homology ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/" tabindex="-1" role="menuitem">All Homology Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#literature" tabindex="-1" role="menuitem" class="expandRight">Literature</a><ul class="actual-resources-submenu literature ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nlmcatalog/journals" title=" Information on journals cited by NCBI records " tabindex="-1" role="menuitem">Journals in NCBI Databases</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mesh" title=" Controlled vocabulary for MEDLINE " tabindex="-1" role="menuitem">MeSH Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/" title=" Reviews of clinical effectiveness research " tabindex="-1" role="menuitem">PubMed Health</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/" tabindex="-1" role="menuitem">All Literature Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#proteins" tabindex="-1" role="menuitem" class="expandRight">Proteins</a><ul class="actual-resources-submenu proteins ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/protein" title=" Protein sequence data " tabindex="-1" role="menuitem">Protein Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/" tabindex="-1" role="menuitem">All Proteins Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#sequence-analysis" tabindex="-1" role="menuitem" class="expandRight">Sequence Analysis</a><ul class="actual-resources-submenu sequence-analysis ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/" tabindex="-1" role="menuitem">All Sequence Analysis Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#taxonomy" tabindex="-1" role="menuitem" class="expandRight">Taxonomy</a><ul class="actual-resources-submenu taxonomy ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/taxonomy" title=" The NCBI taxonomy tree in Entrez " tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Root" title=" Displays and links Entrez data to each taxonomic node " tabindex="-1" role="menuitem">Taxonomy Browser</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi" title=" Creates custom taxonomic trees " tabindex="-1" role="menuitem">Taxonomy Common Tree</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/" tabindex="-1" role="menuitem">All Taxonomy Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#training-tutorials" tabindex="-1" role="menuitem" class="expandRight">Training &amp; Tutorials</a><ul class="actual-resources-submenu training-tutorials ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/education/" title=" Central page providing links to tutorials and training materials " tabindex="-1" role="menuitem">NCBI Education Page</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/" tabindex="-1" role="menuitem">All Training &amp; Tutorials Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#variation" tabindex="-1" role="menuitem" class="expandRight">Variation</a><ul class="actual-resources-submenu variation ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/snp" title=" Database of nucleotide sequence polymorphisms " tabindex="-1" role="menuitem">Database of Single Nucleotide Polymorphisms (dbSNP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/" tabindex="-1" role="menuitem">All Variation Resources...</a></li></ul></li></ul></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a><ul id="howto-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/#howtos" tabindex="-1" role="menuitem">All How To</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/#howtos" tabindex="-1" role="menuitem">Chemicals &amp; Bioassays</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/#howtos" tabindex="-1" role="menuitem">DNA &amp; RNA</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/#howtos" tabindex="-1" role="menuitem">Data &amp; Software</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/#howtos" tabindex="-1" role="menuitem">Domains &amp; Structures</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/#howtos" tabindex="-1" role="menuitem">Genes &amp; Expression</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/#howtos" tabindex="-1" role="menuitem">Genetics &amp; Medicine</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/#howtos" tabindex="-1" role="menuitem">Genomes &amp; Maps</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/#howtos" tabindex="-1" role="menuitem">Homology</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/#howtos" tabindex="-1" role="menuitem">Literature</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/#howtos" tabindex="-1" role="menuitem">Proteins</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/#howtos" tabindex="-1" role="menuitem">Sequence Analysis</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/#howtos" tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/#howtos" tabindex="-1" role="menuitem">Training &amp; Tutorials</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/#howtos" tabindex="-1" role="menuitem">Variation</a></li></ul></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3703233%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3703233%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" style="visibility: hidden;"><img src="./PMC3703233_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="archive-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/journals/279/">Br J Clin Pharmacol</a></li><li class="issue-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/issues/224773/">v.76(1); 2013 Jul</a></li><li class="accid">PMC3703233</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC3703233_files/logo-brjclinpharm.gif" alt="Logo of brjclinpharm" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher&#39;s site" title="Link to Publisher&#39;s site" shape="default" coords="0,0,499,74" href="http://www.blackwellpublishing.com/journal.asp?ref=0306-5251" target="pmc_ext" ref="reftype=publisher&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit">Br J Clin Pharmacol. 2013 Jul; 76(1): 107–113. </span></div><div><span class="fm-vol-iss-date">Published online 2012 Dec 4. </span>  <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1111%2Fbcp.12055" target="pmc_ext" ref="reftype=other&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1111/bcp.12055</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3703233</span></div></div></div></div></div><h1 class="content-title">A semi-mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Delavenne%20X%5Bauth%5D">Xavier Delavenne</a>,<sup>1,</sup><sup>2,</sup><sup>3</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ollier%20E%5Bauth%5D">Edouard Ollier</a>,<sup>1,</sup><sup>2</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Basset%20T%5Bauth%5D">Thierry Basset</a>,<sup>1,</sup><sup>2,</sup><sup>3</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Bertoletti%20L%5Bauth%5D">Laurent Bertoletti</a>,<sup>2,</sup><sup>3,</sup><sup>4</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Accassat%20S%5Bauth%5D">Sandrine Accassat</a>,<sup>4</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Garcin%20A%5Bauth%5D">Arnauld Garcin</a>,<sup>5</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Laporte%20S%5Bauth%5D">Silvy Laporte</a>,<sup>2,</sup><sup>3,</sup><sup>6</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Zufferey%20P%5Bauth%5D">Paul Zufferey</a>,<sup>2,</sup><sup>3,</sup><sup>5</sup> and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mismetti%20P%5Bauth%5D">Patrick Mismetti</a><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>6</sup></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id374137_ai" style="display:none"><div class="fm-affl" lang="en"><sup>1</sup>Laboratoire de Pharmacologie Toxicologie, CHU Saint-Etienne, F-42055, Saint-Etienne</div><div class="fm-affl" lang="en"><sup>2</sup>Université de Lyon, F-42023, Saint-Etienne</div><div class="fm-affl" lang="en"><sup>3</sup>Groupe de Recherche sur la Thrombose, EA3065, Université de Saint-Etienne, Jean Monnet, F-42023, Saint-Etienne</div><div class="fm-affl" lang="en"><sup>4</sup>Service de Médecine Thérapeutique, CHU de Saint-Etienne, F-42055, Saint-Etienne</div><div class="fm-affl" lang="en"><sup>5</sup>Déperpartement d'anesthésie Réanimation, CHU de Saint-Etienne, F-42055, Saint-Etienne</div><div class="fm-affl" lang="en"><sup>6</sup>Unité de Recherche Clinique Innovation et Pharmacologie, CHU de Saint-Etienne, F-42055, Saint Etienne, France</div><div id="cor1">Dr Xavier Delavenne, EA3065, Laboratory of Pharmacology and Toxicology, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France., Tel.: +334 7712 0572, Fax: +334 7712 7820, E-mail: <a href="mailto:dev@null" data-email="rf.enneite-ts-uhc@ennevaled.reivax" class="oemail">rf.enneite-ts-uhc@ennevaled.reivax</a></div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="pmctoggle" rid="id374137_ai">Author information <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="pmctoggle" rid="id374137_an">Article notes <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="pmctoggle" rid="id374137_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="id374137_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Oct 17; Accepted 2012 Nov 22.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id374137_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a>  © 2013 The British Pharmacological Society</div></div></div><div class="links-box fm-panel whole_rhythm"><div class="small"><div>This article has been <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="__abstractid364404" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid364404title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3>Aim</h3><p id="__p1" class="p p-first-last">The aim of this study was to develop a PK/PD model to assess drug–drug interactions between dabigatran and P-gp modulators, using the example of clarithromycin, a strong inhibitor of P-gp.</p></div><div id="__sec2" class="sec"><h3>Methods</h3><p id="__p2" class="p p-first-last">Ten healthy male volunteers were randomized to receive in the first treatment period a single 300 mg dose of dabigatran etexilate (DE) and in the second treatment period 500 mg clarithromycin twice daily during 3 days and then 300 mg DE plus 500 mg clarithromycin on the fourth day, or the same treatments in the reverse sequence. Dabigatran plasma concentration and ecarin clotting time (ECT) were measured on 11 blood samples. Models were built using a non-linear mixed effect modelling approach.</p></div><div id="__sec3" class="sec"><h3>Results</h3><p id="__p3" class="p p-first-last">The best PK model was based on an inverse Gaussian absorption process with two compartments. The relationship between dabigatran concentration and ECT was implemented as a linear function. No continuous covariate was associated with a significant decrease in the objective function. The concomitant administration of clarithromycin induced a significant change only in DE bioavailability, which increased from 6.5% to 10.1% in the presence of clarithromycin. Clarithromycin increased peak concentration and AUC by 60.2% and 49.1% respectively.</p></div><div id="__sec4" class="sec sec-last"><h3>Conclusion</h3><p id="__p4" class="p p-first-last">The model proposed effectively describes the complex PK of dabigatran and takes into account drug–drug interactions with P-gp activity modulators, such as clarithromycin.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">bioavailability, clarithromycin, dabigatran, drug–drug interaction, P-glycoprotein inhibition, population pharmacokinetics and pharmacodynamics</span></div></div><div id="__bodyid374301" class="tsec sec headless whole_rhythm"><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT</h3><div id="__p5"><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
--><li><div>Dabigatran etexilate has a bioavailability of 6.5% due to a complex absorption process.</div></li><li><div>Dabigatran etexilate is a substrate for P-gp and its reflux can be modulated by other drugs.</div></li><li><div>P-gp inhibitors increase the AUC of dabigatran from about 50% to over 200%.</div></li></ul></div></div></div><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3>WHAT THIS STUDY ADDS</h3><div id="__p9"><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
--><li><div>The pharmacokinetics and pharmacodynamics of dabigatran were described by a two compartment model with an absorption following an inverse Gaussian law, associated with a linear effect model.</div></li><li><div>We showed that this phenomenon is explained solely by an increase in bioavailability from 6.5 to 10%.</div></li><li><div>Exposure to dabigatran is increased by 50% in the presence of clarithromycin and is characterized by substantial variability.</div></li></ul></div></div></div></div><div id="__sec7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec7title">Introduction</h2><p id="__p13" class="p p-first">Dabigatran etexilate (DE) is an anticoagulant drug used for the prevention of venous thromboembolism after orthopaedic surgery and for the long term prevention of stroke in patients with atrial fibrillation <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b1" rid="b1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882925" role="button" aria-expanded="false" aria-haspopup="true">1</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b2" rid="b2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882913" role="button" aria-expanded="false" aria-haspopup="true">2</a>. DE is a synthetic, orally administered prodrug that is rapidly converted into the active drug, dabigatran, by a serum esterase. It exerts its activity by direct competitive inhibition of thrombin. DE has a bioavailability of 6.5% due to a complex absorption process <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b3" rid="b3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882926" role="button" aria-expanded="false" aria-haspopup="true">3</a>, necessitating first, an acid environment for dissolution and second, active transport by P-glycoprotein (P-gp) <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b3" rid="b3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882914" role="button" aria-expanded="false" aria-haspopup="true">3</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b4" rid="b4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882927" role="button" aria-expanded="false" aria-haspopup="true">4</a>. P-gp-mediated transport through the enterocyte, from the basolateral to the apical side, could be involved in the excretion of DE in the gut. Dabigatran is not metabolized by the cytochrome P450 enzyme system and 80% of the dose administered is directly excreted by the kidneys <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b3" rid="b3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882931" role="button" aria-expanded="false" aria-haspopup="true">3</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b5" rid="b5" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">5</a>. In clinical practice, dabigatran can be given as a fixed dose without monitoring.</p><p id="__p14">Compared with other anticoagulant drugs, such as vitamin K antagonists, dabigatran has a low potential for drug–drug interactions. However, it is a substrate for P-gp and its reflux can be modulated by other drugs. P-gp inducers and inhibitors can, respectively, decrease or increase its bioavailability. An increase in dabigatran area under the concentration <em>vs.</em> time curve (AUC), ranging from near 50% to over 200%, has been reported after co-administration of amiodarone, ketoconazole, quinidine or verapamil <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b5" rid="b5" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">5</a>. Some of these drug–drug interactions are strong enough to warrant contraindications or precautions for use. Other interactions involving P-gp modulators might also be clinically relevant and necessitate dose adjustments, possibly based on drug monitoring.</p><p id="__p15" class="p p-last">The aim of this study was to develop a PK/PD model to assess drug–drug interactions between dabigatran and P-gp modulators, using clarithromycin, a strong inhibitor of P-gp, as an example.</p></div><div id="__sec8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec8title">Methods</h2><div id="__sec9" class="sec sec-first"><h3>Study design</h3><p id="__p16" class="p p-first-last">This was a single centre, randomized, open label study with a two-way crossover design (clinical trial.org registration no.: NCT01385683). The protocol complied with the principles of the declaration of Helsinki (2002 version) and those of Good Clinical Practice established by the International Conference on Harmonization. It was approved by the French regulatory authority (AFSSAPS) and the local Ethics Committee.</p></div><div id="__sec10" class="sec"><h3>Participants</h3><p id="__p17" class="p p-first-last">Ten healthy male Caucasian volunteers aged from 18 to 35 years, were included in the study after a complete physical examination and laboratory tests. To be included, subjects had to have normal coagulation test results with respect to the following parameters: platelet count, international normalized ratio, activated partial thromboplastin time (aPPT) and fibrinogen level. Volunteers with renal insufficiency, hepatic insufficiency or a peptic ulcer, and those who presented a lesion at risk of bleeding or had undergone surgery during the month preceding the study, were excluded. Subjects with known hypersensitivity to DE or clarithromycin, or who had taken any medicine during the week before the study were also excluded. Written informed consent was obtained from each volunteer before inclusion in the study and genetic analysis.</p></div><div id="__sec11" class="sec"><h3>Treatment procedure</h3><p id="__p18" class="p p-first-last">Following screening, volunteers were randomized 1:1 to receive either first DE alone and then a combination of DE and clarithromycin, or first the combination treatment and then DE alone. The two treatment periods were separated by a 6 day washout period. In the DE treatment period, each volunteer received, at time zero (<em>t</em>0: 07.30 h), a 300 mg oral dose of DE (two Pradaxa® 150 mg capsules; Boehringer Ingelheim, Ingelheim, Germany). During the DE plus clarithromycin treatment period, volunteers received on the first 3 days 500 mg clarithromycin (Zeclar®, 500 mg tablet, Abott France, France) twice daily (at 09.00 h and 18.00 h). On the 4<sup>th</sup> day they received 300 mg of DE plus 500 mg of clarithromycin at <em>t</em>0 (07.30 h). The clarithromycin administration regimen was chosen on the grounds of its relevance to clinical practice. DE was administered with 300 ml water (150 ml immediately, then 150 ml 30 min later) to subjects in a semi-supine position after an overnight fast of at least 8 h. Standardized meals were served at 12.00 h and 18.00 h.</p></div><div id="__sec12" class="sec"><h3>Sample collection and analysis</h3><p id="__p19" class="p p-first">For pharmacokinetic (PK) and pharmacodynamic (PD) analysis, 5 ml blood samples were drawn in tubes at 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10 and 23.5 h after DE administration for measurement of plasma concentrations of dabigatran. All analyses were performed on venous blood samples collected by venipuncture, using whole blood collected in citrate tubes for PD and heparinized tubes for PK analysis.</p><p id="__p20">Dabigatran plasma concentrations were determined using the validated liquid chromatography-tandem mass spectrometry method <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b6" rid="b6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882929" role="button" aria-expanded="false" aria-haspopup="true">6</a>. The intra- and inter-day precision values were below 11.3% and accuracy was within 93.8% and 108.8%. The lower limit of quantification was 2 μg l<sup>−1</sup>.</p><p id="__p21" class="p p-last">The anticoagulant effect of dabigatran was measured by an ecarin clotting time (ECT) assay, as described by Nowak <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b7" rid="b7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882923" role="button" aria-expanded="false" aria-haspopup="true">7</a>. The intra- and inter-day precision values were below 2.5%. ECT is the reference coagulation test for analysis of dabigatran's anticoagulant effect <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882919" role="button" aria-expanded="false" aria-haspopup="true">8</a>.</p></div><div id="__sec13" class="sec sec-last"><h3>Model development and evaluation</h3><p id="__p22" class="p p-first">Data analysis was performed using MONOLIX non-linear mixed-effects modelling software (version 4.12, release 2; INRIA – Institut National de Recherche en Informatique et en Automatique, France) <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b9" rid="b9" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">9</a>. The stochastic approximation expectation maximization algorithm combined with the Markov chain Monte Carlo simulation procedure was used to estimate the maximum likelihood of the model. The parameters of the model were assumed to be log-normally distributed in the population studied.</p><p id="__p23" class="p">We fitted the PK and PD data to the model to try to identify the mechanism of the interaction. Modelling was performed in several steps. The first step consisted in identifying the structural PK model for dabigatran without clarithromycin. The second step comprised the estimation of PK/PD parameters and relevant covariates. The third step consisted in testing the inter-occasional variability (IOV) on the full data set (with and without clarithromycin). Finally, drug–drug interaction was investigated applying the categorical covariate ‘concomitant treatment’ to model parameters. In our study, we set the population mean value of DE bioavailability when administered alone at 6.5%, as we had no pharmacokinetic data for DE injected intravenously <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b3" rid="b3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882921" role="button" aria-expanded="false" aria-haspopup="true">3</a>.</p><div id="__sec14" class="sec"><h4>Pharmacokinetic model</h4><p id="__p24" class="p p-first">As drug–drug interaction certainly occurs at the absorption level, the main issue in model development was to determine the most relevant absorption process. Zero order, first order and inverse Gaussian absorptions were tested. The inverse Gaussian absorption process was implemented as follows:</p><div id="__p25"><div class="disp-formula"><div class="f"><img src="./PMC3703233_files/bcp0076-0107-mu1.jpg" class="eq-image" alt="equation image" title="equation image"></div></div></div><p id="__p26">where <em>f<sub>A</sub>(t)</em> represents the quantity of DE that passes into the central compartment during the time interval <em>dt</em>, <em>D</em> is the dose administered at time <em>t</em>, <em>F</em> is the bioavailability, MAT is the mean absorption time and CV<sup>2</sup> is the relative dispersion of absorption time <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b10" rid="b10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882930" role="button" aria-expanded="false" aria-haspopup="true">10</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b11" rid="b11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882912" role="button" aria-expanded="false" aria-haspopup="true">11</a>. This type of absorption process is well suited to test interactions based on a change in bioavailability and has already been used to model the mechanism of P-gp inhibition <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b12" rid="b12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882910" role="button" aria-expanded="false" aria-haspopup="true">12</a>.</p><p id="__p27" class="p p-last">One and two compartment models were tested for the structural component of the model.</p></div><div id="__sec15" class="sec"><h4>Pharmacodynamic model</h4><p id="__p28" class="p p-first-last">A linear relationship, previously described in population model analysis, and an E<sub>max</sub> model were evaluated to describe the relationship between the concentration of dabigatran and its effect <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882916" role="button" aria-expanded="false" aria-haspopup="true">8</a>.</p></div><div id="__sec16" class="sec"><h4>Covariate model</h4><p id="__p29" class="p p-first">Body mass index, weight, lean body weight, size, age and creatinine clearance [calculated using the Modification of Diet in Renal Disease (MDRD) and Cockcroft–Gault equations] were tested as continuous covariates on absorption and structural parameters. The concomitant administration of clarithromycin, was included as a categorical covariate in the absorption model in order to test the presence of an interaction between dabigatran and clarithromycin:</p><div id="__p30"><div class="disp-formula"><div class="f"><img src="./PMC3703233_files/bcp0076-0107-mu2.jpg" class="eq-image" alt="equation image" title="equation image"></div></div></div><p id="__p31">where θ<sub>i</sub> is one of the population parameters, <img alt="An external file that holds a picture, illustration, etc.
Object name is bcp0076-0107-mu3.jpg" src="./PMC3703233_files/bcp0076-0107-mu3.jpg" class="equation"> is the typical value of the parameter θ<sub>i</sub>, <img alt="An external file that holds a picture, illustration, etc.
Object name is bcp0076-0107-mu4.jpg" src="./PMC3703233_files/bcp0076-0107-mu4.jpg" class="equation"> is the covariate effect, Clari is equal to 1 during the clarithromycin plus DE treatment period and 0 during the DE alone period, <img alt="An external file that holds a picture, illustration, etc.
Object name is bcp0076-0107-mu5.jpg" src="./PMC3703233_files/bcp0076-0107-mu5.jpg" class="equation">is the inter-patient variability in the absence of clarithromycin, and <img alt="An external file that holds a picture, illustration, etc.
Object name is bcp0076-0107-mu6.jpg" src="./PMC3703233_files/bcp0076-0107-mu6.jpg" class="equation"> is the increase in inter-patient variability in the presence of clarithromycin.</p><p id="__p32" class="p p-last">The covariates were added to the model in accordance with the procedure described elsewhere <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b13" rid="b13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882911" role="button" aria-expanded="false" aria-haspopup="true">13</a>. This involved a forward inclusion step and a backward elimination step. A decrease in the objective function of at least 3.84 was required to identify a significant covariate.</p></div><div id="__sec17" class="sec sec-last"><h4>Model evaluation</h4><p id="__p33" class="p p-first-last">Model evaluation and selection was based on visual inspection of goodness of fit plots, the precision of parameter estimates and a decrease in objective function. The goodness of fit was established by plotting the population predictions of the model <em>vs.</em> observations, the individual predictions <em>vs.</em> observations, and the normalized prediction distribution errors (NPDE) <em>vs.</em> time <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882924" role="button" aria-expanded="false" aria-haspopup="true">14</a>. The visual predictive check (VPC) was generated by simulating 1000 times the parameters of the 10 subjects. The ability of the model to describe the observations was evaluated by inspection of the distribution of the simulated concentrations. Finally, the median parameter values and the 90% prediction interval of the VPC replicates were compared with the observations comprising the original dataset.</p></div></div></div><div id="__sec18" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec18title">Results</h2><div id="__sec19" class="sec sec-first"><h3>Population description</h3><p id="__p34" class="p p-first-last">All the subjects completed the study and were included in the PK and PD analyses. The median age (range) was 22 (18–33) years, median height 180 (175–188) cm and median weight 75 (64–82) kg. With regard to laboratory data, median aPPT (range) was 1.04 (0.9–1.15) s, median plasma fibrinogen concentration 2.25 (1.6–3) g l<sup>−1</sup> and median plasma creatinine concentration 77 (72–95) μmol l<sup>−1</sup>.</p></div><div id="__sec20" class="sec"><h3>Population PK model</h3><p id="__p35" class="p p-first">The best absorption model was that based on an inverse Gaussian absorption process. This was associated with the best objective function value (758.6), first order and zero order absorption processes being associated with objective function values of 959.5 and 946.7, respectively (on the basis of a two compartment structure).</p><p id="__p36">The parameters defining the two compartment structure of the model were the clearance (CL), the inter-compartmental clearance (Q), and the central and peripheral compartments (<em>V</em><sub>c</sub> and <em>V</em><sub>p</sub> respectively). Random effect was tested only on <em>V</em><sub>c</sub> and absorption parameters (<em>F</em>, CV<sup>2</sup> and MAT). No covariance was found between the parameters CL and <em>V</em><sub>c</sub>. Inter-individual variability was estimated for MAT, CV<sup>2</sup>, <em>F</em> and <em>V</em><sub>c</sub><em>.</em> Residual variability was best described using a combined (additive plus proportional) error model. The values of these parameters are shown in Table <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/table/tbl1/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a>.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="tbl1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/table/tbl1/" target="table" rid-ob="ob-tbl1" rid-figpopup="tbl1" class="table img_link icnblk_img figpopup"><img alt="Table 1" title="Table 1" class="small-thumb" src="./PMC3703233_files/saved_resource" src-large="/pmc/articles/PMC3703233/table/tbl1/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/table/tbl1/" target="table" rid-figpopup="tbl1" rid-ob="ob-tbl1">Table 1</a></div><!--caption a4--><div><span>Values of pharmacokinetic and pharmacodynamic parameters</span></div></div></div><p id="__p39" class="p p-last">None of the continuous covariates tested (weight, body mass index, body surface area, creatinine clearance) was associated with a significant decrease in the objective function.</p></div><div id="__sec21" class="sec"><h3>Population PK/PD model</h3><p id="__p40" class="p p-first">The best PK/PD model corresponded to a linear relationship between dabigatran concentration and its anticoagulant effect, based on the ECT, implemented as follows:</p><div id="__p41"><div class="disp-formula"><div class="f"><img src="./PMC3703233_files/bcp0076-0107-mu7.jpg" class="eq-image" alt="equation image" title="equation image"></div></div></div><p id="__p42">where <em>K</em> is a proportionality coefficient, ECT<sub>0</sub> is the baseline ECT value and <em>C</em><sub>Dabi</sub> the plasma concentration of dabigatran. Random effect was tested only on <em>K</em>. The error model was proportional. The values of these parameters are presented in Table <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/table/tbl1/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a>.</p><p id="__p43" class="p p-last">No relevant IOV was estimated on the PK and PD model parameters.</p></div><div id="__sec22" class="sec"><h3>Testing the interaction</h3><p id="__p44" class="p p-first">The administration of clarithromycin induced a significant change only in the bioavailability of DE. The population mean value of <em>F</em> increased from 6.5% (pre-set value; range 2.8–12.1) to 10.1% (4.1–26.9) in the presence of clarithromycin, the inter-individual variability of <em>F</em> increasing from 0.386 to 0.725 (CV%). The modification of the absorption rate of dabigatran and its variability in the presence of clarithromycin is illustrated in Figure <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig01/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -3em;">Figure1.</span></span><span>1</span></a>. The impact of clarithromycin on peak concentration was an increase of 60.2% from (median, min–max) 174.4 μg l<sup>−1</sup> (92.3–310.0) without clarithromycin to 279.4 μg l<sup>−1</sup> (71.6–782.1) with clarithromycin. On AUC, an increase of 49.1% was observed from 1220.5 μg l<sup>−1</sup> h (586.5–2227.2) without clarithromycin to 1820.4 μg l<sup>−1</sup> h (521.0–5000.2) with clarithromycin.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="fig01" co-legend-rid="lgnd_fig01"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01"><img src="./PMC3703233_files/bcp0076-0107-f1.gif" class="small-thumb" alt="Figure 1" title="Figure 1" src-large="/pmc/articles/PMC3703233/bin/bcp0076-0107-f1.jpg"></a><div class="icnblk_cntnt" id="lgnd_fig01"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01">Figure 1</a></div><!--caption a4--><div><span>Absorption rate of dabigatran with and without clarithromycin. The solid black line represents the median absorption rate of dabigatran without clarithromycin (A) and with clarithromycin (B). The dashed lines indicate the 5% and 95% percentiles</span></div></div></div></div><div id="__sec23" class="sec sec-last"><h3>Model evaluation</h3><p id="__p46" class="p p-first">The goodness of fit plots for the model (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S1</a>) show no apparent bias in model prediction except for high concentration and ECT values. The NPDE was not biased. According to the VPC (Figure <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig02/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="fig02" rid-ob="ob-fig02" co-legend-rid="lgnd_fig02"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2),</span></span><span>2</span></a>), average observed values were well predicted and only extreme profiles were outside 90% of the simulated values, showing the good predictive properties of the model.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="fig02" co-legend-rid="lgnd_fig02"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig02/" target="figure" rid-figpopup="fig02" rid-ob="ob-fig02"><img src="./PMC3703233_files/bcp0076-0107-f2.gif" class="small-thumb" alt="Figure 2" title="Figure 2" src-large="/pmc/articles/PMC3703233/bin/bcp0076-0107-f2.jpg"></a><div class="icnblk_cntnt" id="lgnd_fig02"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig02/" target="figure" rid-figpopup="fig02" rid-ob="ob-fig02">Figure 2</a></div><!--caption a4--><div><span>Visual predictive check. The envelope indicates the 90% confidence interval of simulations. The grey circles represent data obtained without clarithromycin. The white circles represent data obtained with clarithromycin</span></div></div></div></div></div><div id="__sec24" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec24title">Discussion</h2><p id="__p48" class="p p-first">Our study showed that the best model to describe the pharmacokinetics and pharmacodynamics of dabigatran in healthy volunteers was a two compartment model with an absorption following an inverse Gaussian law, associated with a linear effect model. To the best of our knowledge, this is the first population model developed on the basis of rich pharmacokinetic and pharmacodynamic data allowing precise description of the complex mechanism of absorption of DE. Other population models published were developed on the basis of patient cohorts receiving thromboembolism prophylaxis after orthopaedic surgery or in the context of atrial fibrillation. These models, based on sparse blood sampling did not allow relevant characterization of the complex absorption of dabigatran DE <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882928" role="button" aria-expanded="false" aria-haspopup="true">8</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b15" rid="b15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882909" role="button" aria-expanded="false" aria-haspopup="true">15</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b16" rid="b16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882918" role="button" aria-expanded="false" aria-haspopup="true">16</a>.</p><p id="__p49">Concerning methodology, we employed an original and powerful statistical approach to test for drug–drug interaction. In contrast to standard bioequivalence approaches, population models are little used, despite their demonstrated superiority for the evaluation of drug–drug interactions in terms of statistical power to demonstrate such interactions <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b17" rid="b17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882922" role="button" aria-expanded="false" aria-haspopup="true">17</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b18" rid="b18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882917" role="button" aria-expanded="false" aria-haspopup="true">18</a>. These models also permit elucidation of the mechanism underlying the interaction. In our case, recourse to an inverse Gaussian model allowed identification of the different stages of the absorption phase and consequently precise evaluation of the drug–drug interaction. This approach has already been successfully used to model P-gp inhibition and its effect on the absorption of digoxin, another P-gp substrate <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b12" rid="b12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882920" role="button" aria-expanded="false" aria-haspopup="true">12</a>.</p><p id="__p50">In our study, clarithromycin increased exposure to dabigatran (AUC) by more than 50%. This increase resulted in a proportional prolongation of coagulation time. We showed that this phenomenon is explained solely by an increase in bioavailability from 6.5 to 10%. This result illustrates perfectly the mechanism involved in the inhibition of P-gp by clarithromycin.</p><p id="__p51">In another study, evaluating the same interaction, the authors showed 19 and 20% increases in AUC and <em>C</em><sub>max</sub>, respectively <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b5" rid="b5" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">5</a>. This difference may be explained by the greater interindividual variability in DE bioavailability observed in the presence of clarithromycin (38.6 <em>vs.</em> 72.5%) in our study, the effect of clarithromycin differing substantially from one volunteer to another (Figure <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig03/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="fig03" rid-ob="ob-fig03" co-legend-rid="lgnd_fig03"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3).</span></span><span>3</span></a>). This variability could be explained by genetic factors, such as polymorphism of the gene coding for P-gp and CES1, which limits the biotransformation of the drug's oral etexilate form to active dabigatran. In a recent follow-up subanalysis of the RE-LY study (atrial fibrillation treated with dabigatran etexilate), the authors identified a common gene variant that seems to influence the bleeding risk associated with the drug <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b2" rid="b2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_322882915" role="button" aria-expanded="false" aria-haspopup="true">2</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b19" rid="b19" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">19</a>. Their conclusion is that a genetic polymorphism of ABCB1 (rs4148738) and CES1 (rs8192935) were significantly associated with higher dabigatran peak concentrations.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="fig03" co-legend-rid="lgnd_fig03"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig03/" target="figure" rid-figpopup="fig03" rid-ob="ob-fig03"><img src="./PMC3703233_files/bcp0076-0107-f3.gif" class="small-thumb" alt="Figure 3" title="Figure 3" src-large="/pmc/articles/PMC3703233/bin/bcp0076-0107-f3.jpg"></a><div class="icnblk_cntnt" id="lgnd_fig03"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/figure/fig03/" target="figure" rid-figpopup="fig03" rid-ob="ob-fig03">Figure 3</a></div><!--caption a4--><div><span>Pharmacokinetic profiles of three volunteers. Fit of dabigatran plasma concentration with (solid line) and without (dashed line) clarithromycin. Grey circles represent data obtained without clarithromycin. White circles represent data obtained with clarithromycin</span> <strong>...</strong></div></div></div><p id="__p53" class="p p-last">In conclusion, the proposed model effectively describes the complex pharmacokinetics of dabigatran, allowing drug–drug interactions related to P-gp modulation to be taken into account. Using this model, we showed that exposure to dabigatran is increased by 50% in the presence of clarithromycin and is characterized by substantial variability. In contrast to non-compartmental analysis, the population analysis approach is an efficient tool to investigate other drug–drug interactions with dabigatran concerning P-gp inhibitors, inductors or substrates.</p></div><div id="__ackid376025" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ackid376025title">Acknowledgments</h2><div class="sec"><p id="__p54">This research has received funding support from the University Hospital of Saint-Etienne, and was promoted by the University Hospital of Saint-Etienne.</p></div></div><div id="__sec25" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec25title">Competing Interests</h2><!--/article/back/sec/--><p id="__p55" class="p p-first-last">All authors have completed the Unified Competing Interest from <a href="http://www.icmje.org/coi_disclorure.pdf" ref="reftype=extlink&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://www.icmje.org/coi_disclorure.pdf</a>. and declare there is no support from any organization for the submitted work, no financial relationships with any organization that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work.</p></div><div id="__sec26" class="tsec bk-sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec26title">Supporting Information</h2><!--/article/back/sec/--><p id="__p56" class="p p-first">Additional Supporting Information may be found in the online version of this article at the publisher's web-site:</p><p id="__p57"><strong>Figure S1</strong></p><p id="__p58" class="p">Goodness of fit plots. The grey circles represent data obtained without clarithromycin. The white circles represent data obtained with clarithromycin.The solid line indicates the line of identity. The dashed line indicates the regression line</p><div class="sec suppmat" id="SD1"><div class="sup-box half_rhythm" id="d35e1710"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/bin/bcp0076-0107-SD1.tiff">Click here to view.</a><sup>(415K, tiff)</sup></div></div></div><div id="__ref-listid376055" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-23"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-24">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid376055title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1">1. <span class="element-citation">Eriksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo M-L, Ahnfelt L, Piovela F, Stangier J, Lebo KA, Reilly P. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. <span><span class="ref-journal">J Thromb Haemost. </span>2005;<span class="ref-vol">3</span>:103–111.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15634273" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2">2. <span class="element-citation">Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>:1139–1151.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19717844" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3">3. <span class="element-citation">Blech S, Ebner T, Ludwig-Schwellinger E, Stangier J, Roth W. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans. <span><span class="ref-journal">Drug Metab Dispos. </span>2008;<span class="ref-vol">36</span>:386–399.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18006647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4">4. <span class="element-citation">Stangier J, Eriksson BI, Dahl OE, Ahnfelt L, Nehmiz G, Stähle H, Rathgen K, Svärd R. Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. <span><span class="ref-journal">J Clin Pharmacol. </span>2005;<span class="ref-vol">45</span>:555–563.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15831779" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5">5. <span class="element-citation">CHMP.  Pradaxa, INN- dabigatran etexilate CHMP assessment report for radaxa. EMEA, editor. 2008 Apr 10; 1–36. Available at  <a href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000829/WC500041062.pdf" ref="reftype=extlink&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000829/WC500041062.pdf</a> (last accessed 30 September 2012)</span></div><div class="ref-cit-blk half_rhythm" id="b6">6. <span class="element-citation">Delavenne X, Moracchini J, Laporte S, Mismetti P, Basset T. UPLC MS/MS assay for routine quantification of dabigatran – a direct thrombin inhibitor – in human plasma. <span><span class="ref-journal">J Pharm Biomed Anal. </span>2012;<span class="ref-vol">58</span>:152–156.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21996066" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7">7. <span class="element-citation">Nowak G. The ecarin clotting time, a universal method to quantify direct thrombin inhibitors. <span><span class="ref-journal">Pathophysiol Haemost Thromb. </span>2003;<span class="ref-vol">33</span>:173–183.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15583446" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8">8. <span class="element-citation">Liesenfeld K-H, Schäfer HG, Trocóniz IF, Tillmann C, Eriksson BI, Stangier J. Effects of the direct thrombin inhibitor dabigatran on <em>ex vivo</em> coagulation time in orthopaedic surgery patients: a population model analysis. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2006;<span class="ref-vol">62</span>:527–537.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885168/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17061960" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9">9. <span class="element-citation">Kuhn E, Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. <span><span class="ref-journal">Comput Stat Data Anal. </span>2005;<span class="ref-vol">49</span>:1020–1038.</span></span></div><div class="ref-cit-blk half_rhythm" id="b10">10. <span class="element-citation">Weiss M. A novel extravascular input function for the assessment of drug absorption in bioavailability studies. <span><span class="ref-journal">Pharm Res. </span>1996;<span class="ref-vol">13</span>:1547–1553.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8899849" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11">11. <span class="element-citation">Wang J, Weiss M, D'Argenio DZ. A note on population analysis of dissolution-absorption models using the inverse Gaussian function. <span><span class="ref-journal">J Clin Pharmacol. </span>2008;<span class="ref-vol">48</span>:719–725.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648518/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18359921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12">12. <span class="element-citation">Weiss M, Sermsappasuk P, Siegmund W. Modeling the kinetics of digoxin absorption: enhancement by P-glycoprotein inhibition. <span><span class="ref-journal">J Clin Pharmacol. </span>2012;<span class="ref-vol">52</span>:381–387.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21343347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13">13. <span class="element-citation">Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic – pharmacodynamic models. I. Models for covariate effects. <span><span class="ref-journal">J Pharmacokinet Biopharm. </span>1992;<span class="ref-vol">20</span>:511–528.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1287200" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14">14. <span class="element-citation">Brendel K, Comets E, Laffont C, Mentre F. Evaluation of different tests based on observations for external model evaluation of population analyses. <span><span class="ref-journal">J Pharmacokinet Pharmacodyn. </span>2010;<span class="ref-vol">37</span>:49–65.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874574/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20033477" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15">15. <span class="element-citation">Liesenfeld KH, Lehr T, Dansirikul C, Reilly PA, Connolly SJ, Ezekowitz MD, Yusuf S, Wallentin L, Haertter S, Staab A. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial. <span><span class="ref-journal">J Thromb Haemost. </span>2011;<span class="ref-vol">9</span>:2168–2175.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21972820" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16">16. <span class="element-citation">Trocóniz IF, Tillmann C, Liesenfeld K-H, Schäfer HG, Stangier J. Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery. <span><span class="ref-journal">J Clin Pharmacol. </span>2007;<span class="ref-vol">47</span>:371–382.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17322149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17">17. <span class="element-citation">Panhard X, Mentré F. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials. <span><span class="ref-journal">Stat Med. </span>2005;<span class="ref-vol">24</span>:1509–1524.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15761916" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18">18. <span class="element-citation">Delavenne X, Laporte S, Demasles S, Mallouk N, Basset T, Tod M, Girard P, Mismetti P. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid. <span><span class="ref-journal">Fundam Clin Pharmacol. </span>2009;<span class="ref-vol">23</span>:127–135.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19267776" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19">19. <span class="element-citation">Pare G. RELY- genetics: genetic determinants of dabigatran plasma levels and their relation to clinical response. <span><span class="ref-journal">Eur Heart J. </span>2012;<span class="ref-vol">33</span>:abstr 5170.</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__abstractid364404title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__sec7title">Introduction</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__sec8title">Methods</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__sec18title">Results</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__sec24title">Discussion</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__ackid376025title">Acknowledgments</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__sec25title">Competing Interests</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__sec26title">Supporting Information</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#__ref-listid376055title">References</a></li></ul></div></div><!--post-content--><hr class="whole_rhythm no_bottom_margin"><div class="courtesy-note no_margin small">Articles from <span class="acknowledgment-journal-title">British Journal of Clinical Pharmacology</span> are provided here courtesy of <strong>British Pharmacological Society</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/?report=reader"><img src="./PMC3703233_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/pdf/bcp0076-0107.pdf">PDF (811K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" data-citationid="PMC3703233" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3703233%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3703233_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3703233%2F&amp;text=A%20semi-mechanistic%20absorption%20model%20to%20evaluate%20drug%E2%80%93drug%20interaction%20with%20dabigatran%3A%20application%20with%20clarithromycin" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3703233_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3703233%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3703233_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23210726" data-aiid="3703233" data-aid="3703233" data-iid="224773" data-domainid="279" data-domain="brjclinpharm" data-accid="PMC3703233" data-md5="2693b09e62eafc843edaf96b67da13f0">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-41" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-41" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="3703233"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-43" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-43" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/22252796" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.</a><span class="source">[Eur J Clin Pharmacol. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clemens A, van Ryn J, Sennewald R, Yamamura N, Stangier J, Feuring M, Härtter S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Clin Pharmacol. 2012 May; 68(5):607-16. Epub 2012 Jan 18.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/17506785" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.</a><span class="source">[Br J Clin Pharmacol. 2007]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-47" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stangier J, Rathgen K, Stähle H, Gansser D, Roth W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Br J Clin Pharmacol. 2007 Sep; 64(3):292-303. Epub 2007 May 15.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/22782539" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers.</a><span class="source">[Eur J Clin Pharmacol. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-49" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Härtter S, Sennewald R, Schepers C, Baumann S, Fritsch H, Friedman J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Clin Pharmacol. 2013 Mar; 69(3):327-39. Epub 2012 Jul 11.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/20069135" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Dabigatran etexilate in venous thromboembolism.</a><span class="source">[Drugs Today (Barc). 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-51" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ferrer E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drugs Today (Barc). 2009 Oct; 45(10):715-24. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/18399711" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.</a><span class="source">[Clin Pharmacokinet. 2008]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-53" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stangier J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Pharmacokinet. 2008; 47(5):285-95. </em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23210726&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23210726&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-55" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-55" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715848/" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment</a><span class="source">[Journal of Thrombosis and Thro...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-57" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Burnett AE, Mahan CE, Vazquez SR, Oertel LB, Garcia DA, Ansell J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Journal of Thrombosis and Thrombolysis. 2016 Jan 16; 41206-232</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243910/" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time</a><span class="source">[British Journal of Clinical Ph...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-59" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chin PK, Wright DF, Patterson DM, Doogue MP, Begg EJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">British Journal of Clinical Pharmacology. 2014 Aug 21; 78(3)599-609</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170944/" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin?</a><span class="source">[Clinical medicine reviews in v...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-61" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tan AY, Rosenberg MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clinical medicine reviews in vascular health. 2013 Jun 20; 51-8</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070467/" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Correlation Between Trough Plasma Dabigatran Concentrations and Estimates of Glomerular Filtration Rate Based on Creatinine and Cystatin C</a><span class="source"></span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-63" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chin PK, Wright DF, Zhang M, Wallace MC, Roberts RL, Patterson DM, Jensen BP, Barclay ML, Begg EJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drugs in R&amp;D. 2014 May 6; 14(2)113-123</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067452/" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Management of Nontuberculous Mycobacterial Infection in The Elderly</a><span class="source">[European journal of internal m...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-65" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mirsaeidi M, Farshidpour M, Ebrahimi G, Aliberti S, Falkinham JO III. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">European journal of internal medicine. 2014 Mar 29; 25(4)356-363</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/citedby/" ref="reftype=relart&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-67" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-67" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3703233" ref="reftype=Compound&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-69" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/23210726/" ref="reftype=PubMed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-71" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-73" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-73" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2964f2911de5257dd4f2">A semi-mechanistic absorption model to evaluate drug–drug interaction with dabig...</a><div class="ralinkpop offscreen_noflow">A semi-mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin<div class="brieflinkpopdesc">British Journal of Clinical Pharmacology. 2013 Jul; 76(1)107</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c296104fcfad59176fd0f">PMC3703233 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2946f2911de5257dcff4">CYP3A4/5 combined genotype analysis for predicting statin dose requirement for o...</a><div class="ralinkpop offscreen_noflow">CYP3A4/5 combined genotype analysis for predicting statin dose requirement for optimal lipid control<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2013; 28(1)59</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c292e7fd84438f0ea3bd2">PMC3681953 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c28fd04fcfad59176ecf3">Editor's choice: Impact of common genetic variation on response to simvastatin t...</a><div class="ralinkpop offscreen_noflow">Editor's choice: Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study<div class="brieflinkpopdesc">European Heart Journal. 2013 Apr 1; 34(13)982</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p13" name="crb--__p13" rid="__p13" style="position: absolute; visibility: visible; width: 370px; top: 1494px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-75"><ul>
<li class="two_line" reference_id="b1">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15634273/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.</a><span class="one_line_source">[J Thromb Haemost.  2005]</span><div class="alt-note">
<div class="authors">Eriksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo ML, Ahnfelt L, Piovella F, Stangier J, Kälebo P, Reilly P, BISTRO II Study Group</div>
<div class="citation">J Thromb Haemost. 2005 Jan; 3(1):103-11.</div>
</div>
</li>
<li class="two_line" reference_id="b2">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19717844/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dabigatran versus warfarin in patients with atrial fibrillation.</a><span class="one_line_source">[N Engl J Med.  2009]</span><div class="alt-note">
<div class="authors">Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators</div>
<div class="citation">N Engl J Med. 2009 Sep 17; 361(12):1139-51.</div>
</div>
</li>
<li class="two_line" reference_id="b3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18006647/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.</a><span class="one_line_source">[Drug Metab Dispos.  2008]</span><div class="alt-note">
<div class="authors">Blech S, Ebner T, Ludwig-Schwellinger E, Stangier J, Roth W</div>
<div class="citation">Drug Metab Dispos. 2008 Feb; 36(2):386-99.</div>
</div>
</li>
<li class="two_line" reference_id="b4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15831779/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.</a><span class="one_line_source">[J Clin Pharmacol.  2005]</span><div class="alt-note">
<div class="authors">Stangier J, Eriksson BI, Dahl OE, Ahnfelt L, Nehmiz G, Stähle H, Rathgen K, Svärd R</div>
<div class="citation">J Clin Pharmacol. 2005 May; 45(5):555-63.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p20" name="crb--__p20" rid="__p20" style="position: absolute; visibility: visible; width: 370px; top: 2780px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-76"><ul><li class="two_line" reference_id="b6">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21996066/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasma.</a><span class="one_line_source">[J Pharm Biomed Anal.  2012]</span><div class="alt-note">
<div class="authors">Delavenne X, Moracchini J, Laporte S, Mismetti P, Basset T</div>
<div class="citation">J Pharm Biomed Anal. 2012 Jan 25; 58():152-6.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 2856px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-77"><ul>
<li class="two_line" reference_id="b7" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15583446/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The ecarin clotting time, a universal method to quantify direct thrombin inhibitors.</a><span class="one_line_source">[Pathophysiol Haemost Thromb.  2003]</span><div class="alt-note">
<div class="authors">Nowak G</div>
<div class="citation">Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug; 33(4):173-83.</div>
</div>
</li>
<li class="two_line" reference_id="b8" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17061960/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.</a><span class="one_line_source">[Br J Clin Pharmacol.  2006]</span><div class="alt-note">
<div class="authors">Liesenfeld KH, Schäfer HG, Trocóniz IF, Tillmann C, Eriksson BI, Stangier J</div>
<div class="citation">Br J Clin Pharmacol. 2006 Nov; 62(5):527-37.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/" class="seemore">See links ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p23" name="crb--__p23" rid="__p23" style="position: absolute; visibility: visible; width: 370px; top: 3082px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-78"><ul><li class="two_line" reference_id="b3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18006647/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.</a><span class="one_line_source">[Drug Metab Dispos.  2008]</span><div class="alt-note">
<div class="authors">Blech S, Ebner T, Ludwig-Schwellinger E, Stangier J, Roth W</div>
<div class="citation">Drug Metab Dispos. 2008 Feb; 36(2):386-99.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 3446px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-79"><ul>
<li class="two_line" reference_id="b10">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8899849/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A novel extravascular input function for the assessment of drug absorption in bioavailability studies.</a><span class="one_line_source">[Pharm Res.  1996]</span><div class="alt-note">
<div class="authors">Weiss M</div>
<div class="citation">Pharm Res. 1996 Oct; 13(10):1547-53.</div>
</div>
</li>
<li class="two_line" reference_id="b11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18359921/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A note on population analysis of dissolution-absorption models using the inverse Gaussian function.</a><span class="one_line_source">[J Clin Pharmacol.  2008]</span><div class="alt-note">
<div class="authors">Wang J, Weiss M, D'Argenio DZ</div>
<div class="citation">J Clin Pharmacol. 2008 Jun; 48(6):719-25.</div>
</div>
</li>
<li class="two_line" reference_id="b12" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21343347/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Modeling the kinetics of digoxin absorption: enhancement by P-glycoprotein inhibition.</a><span class="one_line_source">[J Clin Pharmacol.  2012]</span><div class="alt-note">
<div class="authors">Weiss M, Sermsappasuk P, Siegmund W</div>
<div class="citation">J Clin Pharmacol. 2012 Mar; 52(3):381-7.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p28" name="crb--__p28" rid="__p28" style="position: absolute; visibility: visible; width: 370px; top: 3633px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-80"><ul><li class="two_line" reference_id="b8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17061960/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.</a><span class="one_line_source">[Br J Clin Pharmacol.  2006]</span><div class="alt-note">
<div class="authors">Liesenfeld KH, Schäfer HG, Trocóniz IF, Tillmann C, Eriksson BI, Stangier J</div>
<div class="citation">Br J Clin Pharmacol. 2006 Nov; 62(5):527-37.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p32" name="crb--__p32" rid="__p32" style="position: absolute; visibility: visible; width: 370px; top: 4000px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-81"><ul><li class="two_line" reference_id="b13">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/1287200/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.</a><span class="one_line_source">[J Pharmacokinet Biopharm.  1992]</span><div class="alt-note">
<div class="authors">Mandema JW, Verotta D, Sheiner LB</div>
<div class="citation">J Pharmacokinet Biopharm. 1992 Oct; 20(5):511-28.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p33" name="crb--__p33" rid="__p33" style="position: absolute; visibility: visible; width: 370px; top: 4109px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-82"><ul><li class="two_line" reference_id="b14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20033477/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evaluation of different tests based on observations for external model evaluation of population analyses.</a><span class="one_line_source">[J Pharmacokinet Pharmacodyn.  2010]</span><div class="alt-note">
<div class="authors">Brendel K, Comets E, Laffont C, Mentré F</div>
<div class="citation">J Pharmacokinet Pharmacodyn. 2010 Feb; 37(1):49-65.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p48" name="crb--__p48" rid="__p48" style="position: absolute; visibility: visible; width: 370px; top: 5789px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-83"><ul>
<li class="two_line" reference_id="b8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17061960/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.</a><span class="one_line_source">[Br J Clin Pharmacol.  2006]</span><div class="alt-note">
<div class="authors">Liesenfeld KH, Schäfer HG, Trocóniz IF, Tillmann C, Eriksson BI, Stangier J</div>
<div class="citation">Br J Clin Pharmacol. 2006 Nov; 62(5):527-37.</div>
</div>
</li>
<li class="two_line" reference_id="b15">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21972820/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.</a><span class="one_line_source">[J Thromb Haemost.  2011]</span><div class="alt-note">
<div class="authors">Liesenfeld KH, Lehr T, Dansirikul C, Reilly PA, Connolly SJ, Ezekowitz MD, Yusuf S, Wallentin L, Haertter S, Staab A</div>
<div class="citation">J Thromb Haemost. 2011 Nov; 9(11):2168-75.</div>
</div>
</li>
<li class="two_line" reference_id="b16">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17322149/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.</a><span class="one_line_source">[J Clin Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Trocóniz IF, Tillmann C, Liesenfeld KH, Schäfer HG, Stangier J</div>
<div class="citation">J Clin Pharmacol. 2007 Mar; 47(3):371-82.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p49" name="crb--__p49" rid="__p49" style="position: absolute; visibility: visible; width: 370px; top: 5968px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-84"><ul>
<li class="two_line" reference_id="b17">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15761916/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.</a><span class="one_line_source">[Stat Med.  2005]</span><div class="alt-note">
<div class="authors">Panhard X, Mentré F</div>
<div class="citation">Stat Med. 2005 May 30; 24(10):1509-24.</div>
</div>
</li>
<li class="two_line" reference_id="b18">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19267776/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.</a><span class="one_line_source">[Fundam Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Delavenne X, Laporte S, Demasles S, Mallouk N, Basset T, Tod M, Girard P, Mismetti P</div>
<div class="citation">Fundam Clin Pharmacol. 2009 Feb; 23(1):127-35.</div>
</div>
</li>
<li class="two_line" reference_id="b12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21343347/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Modeling the kinetics of digoxin absorption: enhancement by P-glycoprotein inhibition.</a><span class="one_line_source">[J Clin Pharmacol.  2012]</span><div class="alt-note">
<div class="authors">Weiss M, Sermsappasuk P, Siegmund W</div>
<div class="citation">J Clin Pharmacol. 2012 Mar; 52(3):381-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p51" name="crb--__p51" rid="__p51" style="position: absolute; visibility: visible; width: 370px; top: 6242px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-85"><ul><li class="two_line" reference_id="b2">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19717844/" ref="reftype=pubmed&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dabigatran versus warfarin in patients with atrial fibrillation.</a><span class="one_line_source">[N Engl J Med.  2009]</span><div class="alt-note">
<div class="authors">Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators</div>
<div class="citation">N Engl J Med. 2009 Sep 17; 361(12):1139-51.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC3703233_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-b1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.<div class="authors">Eriksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo ML, Ahnfelt L, Piovella F, Stangier J, Kälebo P, Reilly P, BISTRO II Study Group</div><div class="citation">J Thromb Haemost. 2005 Jan; 3(1):103-11.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15634273/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b1">Ref list</a>]</p></div><div id="body-link-popper-b2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Dabigatran versus warfarin in patients with atrial fibrillation.<div class="authors">Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators</div><div class="citation">N Engl J Med. 2009 Sep 17; 361(12):1139-51.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19717844/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b2">Ref list</a>]</p></div><div id="body-link-popper-b3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.<div class="authors">Blech S, Ebner T, Ludwig-Schwellinger E, Stangier J, Roth W</div><div class="citation">Drug Metab Dispos. 2008 Feb; 36(2):386-99.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18006647/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b3">Ref list</a>]</p></div><div id="body-link-popper-b4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.<div class="authors">Stangier J, Eriksson BI, Dahl OE, Ahnfelt L, Nehmiz G, Stähle H, Rathgen K, Svärd R</div><div class="citation">J Clin Pharmacol. 2005 May; 45(5):555-63.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15831779/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b4">Ref list</a>]</p></div><div id="body-link-popper-b5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">5. <span class="element-citation">CHMP.  Pradaxa, INN- dabigatran etexilate CHMP assessment report for radaxa. EMEA, editor. 2008 Apr 10; 1–36. Available at  <a href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000829/WC500041062.pdf" ref="reftype=extlink&amp;article-id=3703233&amp;issue-id=224773&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000829/WC500041062.pdf</a> (last accessed 30 September 2012)</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b5">Ref list</a>]</div><div id="body-link-popper-b6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasma.<div class="authors">Delavenne X, Moracchini J, Laporte S, Mismetti P, Basset T</div><div class="citation">J Pharm Biomed Anal. 2012 Jan 25; 58():152-6.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21996066/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b6">Ref list</a>]</p></div><div id="body-link-popper-b7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> The ecarin clotting time, a universal method to quantify direct thrombin inhibitors.<div class="authors">Nowak G</div><div class="citation">Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug; 33(4):173-83.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15583446/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b7">Ref list</a>]</p></div><div id="body-link-popper-b8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.<div class="authors">Liesenfeld KH, Schäfer HG, Trocóniz IF, Tillmann C, Eriksson BI, Stangier J</div><div class="citation">Br J Clin Pharmacol. 2006 Nov; 62(5):527-37.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17061960/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b8">Ref list</a>]</p></div><div id="body-link-popper-b9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">9. <span class="element-citation">Kuhn E, Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. <span><span class="ref-journal">Comput Stat Data Anal. </span>2005;<span class="ref-vol">49</span>:1020–1038.</span></span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b9">Ref list</a>]</div><div id="body-link-popper-b10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A novel extravascular input function for the assessment of drug absorption in bioavailability studies.<div class="authors">Weiss M</div><div class="citation">Pharm Res. 1996 Oct; 13(10):1547-53.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8899849/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b10">Ref list</a>]</p></div><div id="body-link-popper-b11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A note on population analysis of dissolution-absorption models using the inverse Gaussian function.<div class="authors">Wang J, Weiss M, D'Argenio DZ</div><div class="citation">J Clin Pharmacol. 2008 Jun; 48(6):719-25.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18359921/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b11">Ref list</a>]</p></div><div id="body-link-popper-b12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Modeling the kinetics of digoxin absorption: enhancement by P-glycoprotein inhibition.<div class="authors">Weiss M, Sermsappasuk P, Siegmund W</div><div class="citation">J Clin Pharmacol. 2012 Mar; 52(3):381-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21343347/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b12">Ref list</a>]</p></div><div id="body-link-popper-b13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.<div class="authors">Mandema JW, Verotta D, Sheiner LB</div><div class="citation">J Pharmacokinet Biopharm. 1992 Oct; 20(5):511-28.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1287200/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b13">Ref list</a>]</p></div><div id="body-link-popper-b14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evaluation of different tests based on observations for external model evaluation of population analyses.<div class="authors">Brendel K, Comets E, Laffont C, Mentré F</div><div class="citation">J Pharmacokinet Pharmacodyn. 2010 Feb; 37(1):49-65.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20033477/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b14">Ref list</a>]</p></div><div id="body-link-popper-b15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.<div class="authors">Liesenfeld KH, Lehr T, Dansirikul C, Reilly PA, Connolly SJ, Ezekowitz MD, Yusuf S, Wallentin L, Haertter S, Staab A</div><div class="citation">J Thromb Haemost. 2011 Nov; 9(11):2168-75.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21972820/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b15">Ref list</a>]</p></div><div id="body-link-popper-b16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.<div class="authors">Trocóniz IF, Tillmann C, Liesenfeld KH, Schäfer HG, Stangier J</div><div class="citation">J Clin Pharmacol. 2007 Mar; 47(3):371-82.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17322149/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b16">Ref list</a>]</p></div><div id="body-link-popper-b17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.<div class="authors">Panhard X, Mentré F</div><div class="citation">Stat Med. 2005 May 30; 24(10):1509-24.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15761916/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b17">Ref list</a>]</p></div><div id="body-link-popper-b18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.<div class="authors">Delavenne X, Laporte S, Demasles S, Mallouk N, Basset T, Tod M, Girard P, Mismetti P</div><div class="citation">Fundam Clin Pharmacol. 2009 Feb; 23(1):127-35.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19267776/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b18">Ref list</a>]</p></div><div id="body-link-popper-b19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">19. <span class="element-citation">Pare G. RELY- genetics: genetic determinants of dabigatran plasma levels and their relation to clinical response. <span><span class="ref-journal">Eur Heart J. </span>2012;<span class="ref-vol">33</span>:abstr 5170.</span></span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#b19">Ref list</a>]</div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:24:37-04:00&amp;Host=ptpmc202">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC3703233_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC3703233_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC3703233_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703233/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=brjclinpharm&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC3703233/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc202 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC3703233_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul><div class="ui-ncbipopper-arrow-image ui-ncbipopper-arrow-right" style="display: none; top: -100px; left: -100px; opacity: 1;">&nbsp;</div></body></html>